Subscribe to our Newsletters !!
Fermentation is a natural method which is applied
With the MAGIO series, Julabo is expanding its pro
The human metapneumovirus, more simply referred to
We are truly honored to share that HiMedia Laborat
Alembic Pharmaceuticals Limited (Alembic) announce
'Simplicity' seems to be the perfect word to descr
Dear Readers, Welcome to the latest issue of Mi
Seegene Inc Seol Korea based company used newly created artificial intelligence (AI)-based assay development system to develop two multiplexed molecular diagnostics for meningitis and Sexually transmitted Diseases.
The assays are based on Allplex real-time polymerase chain reaction (PCR) reagents designed to detect eight different DNA targets simultaneously.
The Seegene digitized development system automates real-time PCR assay development, driving down the cost of molecular diagnostic tests and enabling nonprofessionals to develop multiplexed assays.
The company’s pipeline of products includes assays that diagnose not only infectious diseases but also drug-resistant pathogens, genetic disorders, and various cancers, including breast, colon, and lung cancers.
For more information
